Favourable response to ketogenic dietary therapies: Undiagnosed glucose 1 transporter deficiency syndrome is only one factor

Developmental Medicine and Child Neurology

Volumn 57, Issue 10, 2015, Pages 969-976

  Schoeler, Natasha E ^a,b   Cross, Judith Helen ^b,c,d   Drury, Suzanne ^d   Lench, Nicholas ^d,e   Mcmahon, Jacinta M ^f   Mackay, Mark T ^g,h   Scheffer, Ingrid E ^f,g   Sander, Josemir W ^a,i,j   Sisodiya, Sanjay M ^a,j  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c YOUNG EPILEPSY   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^e Great Ormond Street Hospital for Children ^*  (United Kingdom)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

^h MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

ⁱ STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^j EPILEPSY SOCIETY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER; SLC2A1 PROTEIN, HUMAN;

ANTICONVULSANT THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; DRUG TREATMENT FAILURE; EPILEPSY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME; HUMAN; KETOGENIC DIET; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; TREATMENT RESPONSE; CARBOHYDRATE METABOLISM, INBORN ERRORS; DEFICIENCY; DIET THERAPY; GENETICS; GENOTYPING TECHNIQUE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SEIZURE; TREATMENT OUTCOME;

CARBOHYDRATE METABOLISM, INBORN ERRORS; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; GENOTYPING TECHNIQUES; GLUCOSE TRANSPORTER TYPE 1; HUMANS; KETOGENIC DIET; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; SEIZURES; TREATMENT OUTCOME;

EID: 84940955880     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12781     Document Type: Article

References (26)

1. Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 2008; 7: 500-6.
2. Klepper J, Leiendecker B. GLUT1 deficiency syndrome - 2007 update. Dev Med Child Neurol 2007; 49: 707-16.
3. Young CD, Lewis AS, Rudolph MC, et al. Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo. PLoS ONE 2011; 6: e23205.
4. Hashimoto N, Kagitani-Shimono K, Sakai N, et al. SLC2A1 gene analysis of Japanese patients with glucose transporter 1 deficiency syndrome. J Hum Genet 2011; 56: 846-51.
5. Leen WG, Klepper J, Verbeek MM, et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010; 133: 655-70.
6. Ramm-Pettersen A, Nakken KO, Haavardsholm KC, Selmer KK. Occurrence of GLUT1 deficiency syndrome in patients treated with ketogenic diet. Epilepsy Behav 2014; 32: 76-8.
7. Schoeler NE, Cross JH, Sander JW, Sisodiya SM. Can we predict a favourable response to Ketogenic Diet Therapies for drug-resistant epilepsy? Epilepsy Res 2013; 106: 1-16.
8. Pearson TS, Akman C, Hinton VJ, Engelstad K, De Vivo DC. Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS). Curr Neurol Neurosci Rep 2013; 13: 342.
9. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-60.
10. Koboldt DC, Chen K, Wylie T, et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 2009; 25: 2283-5.
11. Menashe I, Rosenberg PS, Chen BE. PGA: power calculator for case-control genetic association analyses. BMC Genet 2008; 9: 36.
12. Kasperaviciute D, Catarino CB, Heinzen EL, et al. Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. Brain 2010; 133: 2136-47.
13. Arsov T, Mullen SA, Rogers S, et al. Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann Neurol 2012; 72: 807-15.
14. Chamary JV, Parmley JL, Hurst LD. Hearing silence: non-neutral evolution at synonymous sites in mammals. Nat Rev Genet 2006; 7: 98-108.
15. Hunt R, Sauna Z, Ambudkar S, Gottesman M, Kimchi-Sarfaty C. Silent (synonymous) SNPs: should we care about them? Methods Mol Biol 2009; 578: 23-39.
16. Chatterjee S, Pal JK. Role of 5′- and 3′-untranslated regions of mRNAs in human diseases. Biol Cell 2009; 101: 251-62.
17. Tzadok M, Nissenkorn A, Porper K, et al. The many faces of glut1 deficiency syndrome. J Child Neurol 2014; 29: 349-59.
18. Ramm-Pettersen A, Nakken KO, Skogseid IM, et al. Good outcome in patients with early dietary treatment of GLUT-1 deficiency syndrome: results from a retrospective Norwegian study. Dev Med Child Neurol 2013; 55: 440-7.
19. Klepper J, Scheffer H, Leiendecker B, et al. Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2- to 5-year follow-up of 15 children enrolled prospectively. Neuropediatrics 2005; 36: 302-8.
20. Hallbook T, Lundgren J, Ingmar R. Ketogenic diet improves sleep quality in children with therapy-resistant epilepsy. Epilepsia 2007; 48: 59-65.
21. Kossoff EH, Mcgrogan JR, Bluml RM, et al. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 2006; 47: 421-4.
22. Farasat S, Kossoff EH, Pillas DJ, et al. The importance of parental expectations of cognitive improvement for their children with epilepsy prior to starting the ketogenic diet. Epilepsy Behav 2006; 8: 406-10.
23. Nordli DR, Kuroda MM, Carroll J, et al. Experience with the ketogenic diet in infants. Pediatrics 2001; 108: 129-33.
24. Pulsifer MB, Gordon JM, Brandt J, Vining EP, Freeman JM. Effects of ketogenic diet on development and behavior: preliminary report of a prospective study. Dev Med Child Neurol 2001; 43: 301-6.
25. Lambrechts DA, Bovens MJ, De La Parra NM, et al. Ketogenic diet effects on cognition, mood, and psychosocial adjustment in children. Acta Neurol Scand 2013; 127: 103-8.
26. Klepper J. Absence of SLC2A1 mutations does not exclude Glut1 deficiency syndrome. Neuropediatrics 2013; 44: 235-6.